1015 Insulin-induced gene (Insig) homologs
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 1 | 0.0 | 73× | not tested | |
| Lipids and lipid-like molecules | 2 | 0.2 | 9.11× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02448 | TDA | N-Tridecanoic Acid | 1 |
| DB02451 | BNG | B-nonylglucoside | 1 |
| DB04705 | HC3 | 25-Hydroxycholesterol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AJP | Digitonin | 1 |
| BNG | nonyl beta-D-glucopyranoside | 1 |
| CLR | CHOLESTEROL | 1 |
| D10 | DECANE | 1 |
| HC3 | 25-HYDROXYCHOLESTEROL | 1 |
| LBR | (2S)-1-[(13-bromotridecanoyl)oxy]-3-hydroxypropan-2-yl tetradecanoate | 1 |
| TDA | N-TRIDECANOIC ACID | 1 |